Atara Biotherapeutics
ATRA
ATRA
139 hedge funds and large institutions have $316M invested in Atara Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 49 increasing their positions, 54 reducing their positions, and 24 closing their positions.
Holders
139
Holders Change
-15
Holders Change %
-9.74%
% of All Funds
2.24%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
49
Reduced
54
Closed
24
Calls
$5.13M
Puts
$26K
Net Calls
+$5.11M
Net Calls Change
+$5.34M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$20.5M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$4.58M |
| 3 |
3
D.E. Shaw & Co
New York
|
$11.6M |
| 4 |
4
Nuveen Asset Management
Chicago,
Illinois
|
$4.18M |
| 5 |
5
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$3.16M |
